Literature DB >> 8626088

Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR.

M Bonnet1, S Guenoun.   

Abstract

BACKGROUND: Previous studies have shown that grade B proliferate vitreoretinopathy (PVR) is a considerable risk factor for the development of severe postoperative PVR. We conducted a prospective study to elucidate which surgical procedures used in retinal detachment management may stimulate the PVR process in such eyes.
MATERIALS AND METHODS: The study included 156 eyes of 152 consecutive patients with rhegmatogenous retinal detachment complicated by grade B PVR referred before any failed surgery and operated on between 1983 and 1993. The parameters evaluated by multivariate statistical analysis included the cumulative circumferential extent of the retinal tears, the extent of the scleral buckle, gas injection, vitrectomy, the method used for retinopexy, and the time of surgical management during the period of the study.
RESULTS: The incidence of severe postoperative PVR was 25.8% in eyes managed with cryotreatment versus 2.2% in eyes managed with argon laser photocoagulation (P = 0.001). The rate of severe postoperative PVR was not influenced by the other surgical variables.
CONCLUSION: We conclude that cryotherapy may be a risk factor for the development of severe postoperative PVR in retinal detachments associated with grade B PVR.

Entities:  

Mesh:

Year:  1995        PMID: 8626088     DOI: 10.1007/bf00184091

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor.

Authors:  M Bonnet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

2.  Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells.

Authors:  P A Campochiaro; I H Kaden; J Vidaurri-Leal; B M Glaser
Journal:  Arch Ophthalmol       Date:  1985-03

3.  Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells.

Authors:  B M Glaser; J Vidaurri-Leal; R G Michels; P A Campochiaro
Journal:  Ophthalmology       Date:  1993-04       Impact factor: 12.079

4.  The pathophysiology of proliferative vitreoretinopathy in its management.

Authors:  S J Ryan
Journal:  Am J Ophthalmol       Date:  1985-07-15       Impact factor: 5.258

5.  Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells.

Authors:  J S Vidaurri-Leal; B M Glaser
Journal:  Arch Ophthalmol       Date:  1984-09

6.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

7.  Serum contains chemoattractants for human retinal pigment epithelial cells.

Authors:  P A Campochiaro; J A Jerdan; B M Glaser
Journal:  Arch Ophthalmol       Date:  1984-12

8.  An updated classification of retinal detachment with proliferative vitreoretinopathy.

Authors:  R Machemer; T M Aaberg; H M Freeman; A R Irvine; J S Lean; R M Michels
Journal:  Am J Ophthalmol       Date:  1991-08-15       Impact factor: 5.258

  8 in total
  11 in total

1.  Vitrectomy with and without scleral buckle for inferior retinal detachment.

Authors:  Y Y Y Kwong; C W Tsang; W W Lai; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Results of scleral buckling operations in primary rhegmatogenous retinal detachment.

Authors:  E C La Heij; P F Derhaag; F Hendrikse
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

3.  Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

Authors:  M Bonnet; J Fleury; S Guenoun; A Yaniali; C Dumas; C Hajjar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

4.  Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

Authors:  N Duquesne; M Bonnet; P Adeleine
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-11       Impact factor: 3.117

Review 5.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2021-10-18       Impact factor: 1.779

6.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

Review 7.  [Proliferative vitreoretinopathy process-To heal or not to heal].

Authors:  S Grisanti; S Priglinger; L Hattenbach
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

8.  Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol.

Authors:  Rishika Chaudhary; Janine Dretzke; Robert Scott; Ann Logan; Richard Blanch
Journal:  Syst Rev       Date:  2016-07-08

Review 9.  Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy.

Authors:  Hiroki Kaneko; Hiroko Terasaki
Journal:  Transl Vis Sci Technol       Date:  2017-07-10       Impact factor: 3.283

Review 10.  Scleral buckle surgery in Ghana: a decade comparison of the anatomic and visual outcome.

Authors:  Imoro Z Braimah; Stephen Akafo; Jay Chhablani
Journal:  Clin Ophthalmol       Date:  2018-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.